Adding to the Medtronic portfolio of catheter-based lead solutions, the novel OmniaSecure defibrillation lead allows for precise delivery and placement in the right ventricle Heart Rhythm 2025: ...
A small-diameter, defibrillation lead that can be delivered through existing commercially available catheters for targeted placement is durable and safe, with no incidence of fractures at 1 year, the ...
BOSTON — An investigative small-diameter defibrillation lead for implantable cardioverter-defibrillators has exceeded its safety and efficacy expectations in a pivotal clinical trial. The LEADR trial ...
AtaCor, a cardiac rhythm management (CRM) company, develops extravascular defibrillation technologies. Its offerings aim to ...
Cardiac device therapy has significantly evolved since the introduction of the first implantable pacemaker and the subsequent ...
Please provide your email address to receive an email when new articles are posted on . A novel defibrillation lead beat safety and efficacy goals in a pivotal trial. The goal of physicians is for the ...
Some patients are having their defibrillation leads taken out early due to shock coil calcification, according to an FDA alert. Boston Scientific has informed healthcare providers that device leads ...
The US Food and Drug Administration has approved Medtronic's novel "extravascular" implantable cardioverter-defibrillator (Aurora EV-ICD) system, which uses a single lead implanted substernally to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results